Oral enasidenib demonstrates durable CRs in IDH2 mutant relapsed, refractory AML August 03, 2017Vol.40 No.07
Drugs & Targets FDA approves Vectibix for use in wild-type ras metastatic colorectal cancer July 06, 2017Vol.40 No.06
Strategy for pancreatic cancer uses engineered exosomes targeting mutated KRAS gene July 06, 2017Vol.40 No.06
Breast cancer drug ineffective in treating squamous non-small cell lung cancer July 06, 2017Vol.40 No.06
